Related Experiment Video
Updated: Jan 10, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular risk factor burden and adverse pregnancy outcomes in women with cardiovascular disease
Valerie C Nemov1, Alden Dunham1, Claudio Schenone Giugni2
1University of South Florida, Morsani College of Medicine; 560 Channelside Drive, Tampa, FL, 33602, USA.
Insights
Pre-conception cardiovascular risk factors did not predict adverse pregnancy outcomes in women with cardiovascular disease. However, higher risk burdens were linked to pre-term birth, highlighting the need for optimizing cardiovascular health before pregnancy.
Area of Science:
- Cardiology
- Obstetrics
- Reproductive Health
Background:
- Cardiovascular disease (CVD) in women poses risks during pregnancy.
- Adverse pregnancy outcomes (APOs) like pre-term birth are associated with future maternal CVD.
- Understanding pre-conception risk factors is crucial for managing pregnancy in women with CVD.
Purpose of the Study:
- To investigate the association between pre-conception cardiovascular risk factor burden and APOs in women with pre-existing CVD.
- To identify specific APOs influenced by cardiovascular risk.
- To inform strategies for improving pregnancy outcomes in this high-risk population.
Main Methods:
- A patient registry from a cardio-obstetrics program was utilized.
- APOs were defined as intrauterine growth restriction (IUGR), hypertensive disorder of pregnancy (HDP), and pre-term birth.
- Statistical analysis was performed on data from 63 women.
Main Results:
- Overall, 33.3% of women experienced at least one APO.
- Pre-conception risk factor burden was not a significant predictor of overall APO development (p=0.139).
- Significantly higher cardiovascular risk factor burdens were observed in women with pre-term delivery (p<0.001) and those with chronic hypertension with superimposed HDP (p<0.001).
Conclusions:
- While overall pre-conception risk burden may not predict all APOs, it is significantly associated with pre-term birth in women with CVD.
- Optimizing cardiovascular health before conception is vital for mitigating risks, particularly pre-term delivery, in women with cardiovascular disease.
- This emphasizes the importance of preconception care in cardio-obstetrics.
Introduction:
We investigated associations between pre-conception cardiovascular risk factor burden and adverse pregnancy outcomes (APOs) in women with cardiovascular disease (CVD).
Methods:
We created a patient registry from our cardio-obstetrics program. APOs were defined as intrauterine growth restriction (IUGR), hypertensive disorder of pregnancy (HDP), and pre-term birth.
Results:
Analysis included 63 women. 42 (66.7 %) experienced no APOs, while 21 (33.3 %) did; 18 (28.6 %), 3 (4.8 %), and 12 (19.0 %) developed an HDP, IUGR, or delivered pre-term, respectively. Pre-conception risk burden was not a significant predictor of APO development (p = 0.139). However, patients with pre-term delivery had a significantly higher number of risk factors (p < 0.001), as did patients with chronic hypertension with superimposed HDP (p < 0.001).
Discussion:
Women delivering pre-term have higher risk factor burdens. Since pre-term birth is associated with future CVD in women independent of cause, optimization of preconception cardiovascular health could help mitigate these risks in an already vulnerable population.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiovascular Drugs: Classification based on Therapeutic Indications

